In the News

Aravind Asokan

November 30, 2022 | Duke School of Medicine

Aravind Asokan to Lead Partnership with Danaher Corporation to Accelerate Gene Therapy Breakthroughs 

Aravind Asokan will lead a new strategic partnership with Danaher Corporation to form the first Danaher Beacon for Gene Therapy Innovation, a new initiative designed to access breakthrough science to create technologies and applications that will improve human health.

Charlie Gersbach

November 16, 2022 | Duke Research Blog

Gersbach Among Most Cited Scientists

Gersbach is one of 30 Duke faculty to make this year's list

Aravind Asokan

November 11, 2022 | Cision PR Newswire

Danaher Launches Beacon Initiative and Its First Partnership Focused on Gene Therapy Innovation

Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced that it has entered a strategic partnership with Duke University to form its first Danaher Beacon for Gene Therapy Innovation.

Kris Wood

October 13, 2022 | WRAL TechWire

Kris Wood startup Tavros Therapeutics strikes $430M deal with Bayer subsidiary

The oncology startup Tavros Therapeutics has signed a five-year collaboration with Vividion Therapeutics that could bring as much as $430.5 million to the RTP firm.

Tagging and illuminating only the inhibitory “brake” cells (green) in human brain tissue is just one of many things the new tool, CellREADR, can do

October 5, 2022 | Duke Today

New RNA-based Tool Can Illuminate Brain Circuits, Edit Specific Cells

Editing technology is precise and broadly applicable to all tissues and animal species

October 4, 2022 | Duke CTSI

Duke Kannapolis Director Outlines Future at North Carolina Research Campus

Svati H. Shah, MD, MHS, spoke to partners at the North Carolina Research Campus (NCRC) about the pivotal role of Duke Kannapolis at the 350-acre translational science hub focused on human health and nutrition.

Anoop Patel

September 6, 2022

Anoop Patel joins Duke, CAGT

We are excited to welcome Anoop Patel, MD, associate professor of neurosurgery, to the CAGT community. Patel graduated magna cum laude from Harvard Medical School and completed residency as well as a research fellowship at Massachusetts General Hospital. He comes to Duke [...]

July 1, 2022

Pranam Chatterjee Joins Duke, CAGT

We are excited to welcome Pranam Chatterjee, PhD, assistant professor of biomedical engineering, to the CAGT community.  Chatterjee's research focus explores how to develop cells and tissues that can improve reproductive longevity and fertility.  “The work that I do is very [...]

Kris Wood

June 6, 2022

Locking Leukemia’s Cellular Escape Hatch

By Alissa Kocer Leukemia starts in cells that would normally develop into different types of blood cells. About 61,000 people in the U.S. are diagnosed each year, and depending on the type of leukemia and the age of the patient, five-year survival rates vary between about [...]

Charlie Gersbach

April 28, 2022 | Gilbert Family Foundation

Gersbach awarded $1.2M Gilbert Family Foundation grant for Gene Therapy Initiative

The Gilbert Family Foundation, announced more than $18 million in grants to fund a new three-year campaign as part of the organization’s Gene Therapy Initiative.

This is a rendering of mRNA, which was successfully used by Emory researchers to modulate gene expression in animal models. The finding could have application for several diseases, including cancer.

April 20, 2022 | Emory News Center

Duke, Emory collaboration successfully uses mRNA to activate genes

What if we could regulate the way genes are expressed? That question has long intrigued researchers, and a new collaboration between Duke and Emory University helps narrow the knowledge gap by showing for the first time that mRNA can be used to activate genes in animals.

IV line with machine in view

March 31, 2022 | Duke Health News

Cancer Repair Mechanism Could Be Potential Drug Target

Disrupting a key cell repair mechanism could extend the benefit of targeted therapies

trainee and mentor standing in front of scientific poster

March 10, 2022

Dedicated to Mentoring

At Duke, mentoring isn't just about trainees' scientific development. Our faculty care about our trainees' growth as individuals too.

duke center for advanced genomic technologies genome technology fellows; two headshots - one woman, one man

February 11, 2022

CAGT names first Genome Technology Fellows

The Center for Advanced Genomic Technologies (CAGT) provided fellowships to support postdoctoral trainees who are conducting research to develop and apply genomic technologies and methods for associated computational analyses to basic and applied biomedical sciences. We [...]

February 11, 2022 | Duke Precision Genomics Collaboratory

Announcing the Genomic Technologies Pilot Grant Winners

February 7, 2022 | Pratt School of Engineering

Tweaked Genes Borrowed From Bacteria Excite Heart Cells in Live Mice

First approach to promote electrical excitation of heart cells in live mammals could lead to new gene therapy treatments for a wide range of heart diseases

Jennifer Doudna holding a model of CRISPR-Cas9

October 25, 2021 | Duke School of Medicine

CRISPR at a Tipping Point: A Q&A with Nobel Laureate Jennifer Doudna

Jennifer Doudna, PhD, professor of chemistry, biochemistry, and molecular biology at the University of California, Berkeley, is a leading figure in the CRISPR revolution. Her fundamental work and leadership in developing the CRISPR-Cas9 genome editing tool earned her and French microbiologist Emmanuelle Charpentier the Nobel Prize in Chemistry in 2020.

i3N iPSC-derived human neurons at 21 DPI. Nuclei are stained with DAPI, neurons are marked by Tubulin, and glutamatergic synapses by PSD95

October 7, 2021

West receives grant from Ruth K. Broad Research Foundation for Alzheimer research

Anne West, MD, PhD, professor of neurobiology, received a Faculty Scholar Award from the Ruth K Broad Biomedical Research Foundation to study noncoding regulation of gene transcription in human neurons. This three-year, $375,000 grant will leverage what researchers already [...]

Charlie Gersbach, Greg Crawford, Tim Reddy, Andrew Allen, David Page, Sayan Mukherjee

September 9, 2021

Two new NIH-funded centers to explore impacts of genomic variation in health, disease

Duke University is the recipient of two large grants totaling nearly $12 million from NHGRI.

PDX1 immunostaining of liver tissue sections at 14 d after injection of mice treated with control and Pdx1-targeted gRNAs. Scale bars, 50 µm.

August 2, 2021

New Mice Enable CRISPR-based Epigenome Editing in Living Animals

A CRISPR-Cas9 variant with deactivated DNA-cutting function – known as “dCas9” - is a powerful tool to help researchers understand what genes do when their expression is dialed up or down, but it has some limitations.

Nasdaq highlights Xilis on their tower in Times Square

July 12, 2021 | Duke Translation & Commercialization

Cancer treatment startup started by Duke faculty raises $70M

Pages